A tongkat ali explainer reports possible testosterone changes. Read the evidence limits, safety concerns and context for low energy and libido.
On October 14, 2026, Ubie published a clinical explainer on tongkat ali (Eurycoma longifolia) and its possible testosterone effects and safety concerns. The article reviewed existing research rather than announcing a new trial or treatment guideline.
This article is for informational purposes only and is not medical advice. Personal decisions about symptoms, supplements or hormone treatment belong with a qualified clinician.
Ubie describes tongkat ali as a traditional herbal supplement also known as longjack. Its central claim is that the herb may modestly increase testosterone in some men, particularly those with low baseline levels.
The explainer reports that a randomized, placebo-controlled trial in men ages 25 to 65 found a 14 to 18 percent increase in salivary testosterone after 12 weeks. That is the main numerical finding highlighted in its discussion of hormone effects. It should remain attached to that specific trial description rather than become a general promise about the supplement.
The reference list also includes a 2021 trial examining tongkat ali alongside concurrent training in men with symptoms of age-related androgen deficiency. The cited paper’s title describes a six-month, double-blind, placebo-controlled randomized trial. This is a separate study from the shorter trial discussed above.
Ubie also cites a 2022 systematic review and meta-analysis of clinical trials. These references show that tongkat ali has been studied in human research. Their presence alone does not settle how a particular man’s symptoms or testosterone results should be interpreted.
The explainer discusses cortisol reduction, changes in sex hormone binding globulin (SHBG) and possible effects on testosterone-producing Leydig cells. It presents these as possible explanations for hormone changes.
For readers comparing supplement claims, the distinction between a proposed mechanism and an observed result matters. A claim about how an herb might act asks a different question from whether it produced a useful outcome in a clinical trial. Both questions belong in an evidence review rather than being treated as interchangeable.
Ubie lists several possible adverse effects associated with tongkat ali. Its cautions cover sleep, mood and physical symptoms:
The explainer also flags rare liver-enzyme increases, possible medication interactions and product-contamination concerns. Those cautions are part of its overall assessment of the supplement rather than an argument that a potential testosterone change should be considered on its own.
This makes the safety discussion relevant to the same concerns that may bring someone to the supplement. A man researching energy or well-being needs information about the whole experience of use, not only a favorable laboratory result. The reported hormone finding and the safety cautions therefore belong in the same conversation.
Ubie specifically warns against assuming that low energy or reduced libido must reflect low testosterone. It names several other possible causes:
According to the explainer, a supplement will not address those underlying causes. The practical question is therefore broader than whether tongkat ali changes a hormone measurement. It includes why the symptom is happening and what a qualified clinician finds relevant to that person’s history.
Testostra’s discussion of fatigue in a hormone assessment provides related context for that distinction. The concern is not whether tiredness deserves attention. It is whether testosterone has been assumed to be the explanation before the wider clinical picture has been considered.
Medication use is another topic raised by Ubie’s list of possible causes. Readers preparing for a clinical conversation can also review how medicines fit into hormonal and sexual concerns. That background supports discussion with a clinician rather than a decision to change prescribed medication independently.
Ubie’s summary does not identify the trial’s full citation directly beside the reported percentage. It does not provide enough detail there to independently assess that figure. The result should therefore be understood as a finding reported by the explainer rather than an independently confirmed estimate of what users should expect.
The measurement was salivary testosterone. A change in saliva is not automatically interchangeable with a change in serum testosterone measured in blood. The explainer also does not establish that the reported increase produced a clinically meaningful improvement in energy, libido or other symptoms.
The useful distinction is between a measurable change and a meaningful benefit. The percentage addresses the former. The material summarized here does not resolve the latter.
Ubie’s overall assessment is that results vary and larger trials are needed. Its emphasis on men with low baseline testosterone should not be extended into a claim that all men will respond in the same way.
For the trial involving concurrent training, the explainer does not supply group sizes or numerical outcomes. Those missing details prevent a useful comparison of the groups or an assessment of how the supplement and training contributed to any result. The study’s title is not a substitute for its findings.
These limits matter when moving from a study population to an individual reader. The evidence described by Ubie does not provide a reliable way to predict who will experience a useful change.
Some hormonal-axis explanations discussed in the explainer draw on animal evidence. Such findings should not be presented as established explanations for testosterone changes in men.
The proposals involving cortisol and SHBG also remain possible mechanisms rather than proven clinical pathways. They may help frame research questions. They do not establish that tongkat ali corrects a particular reader’s hormone function or explains his symptoms.
The explainer does not quantify how often its listed adverse effects occur. It also does not establish that tongkat ali caused every reported concern. Its description of rare liver-enzyme increases should not be expanded into a claim that the supplement commonly causes liver damage.
Ubie says risk may depend on the dose, extract quality and duration of use. The evidence summarized here does not establish a standard dosing regimen or supplement-use routine. There is also no quantified basis in the explainer for comparing the safety of different products.
The appropriate reading is that these are potential concerns to discuss, not a complete or precisely measured risk profile.
The page lists Yoshinori Abe, MD, an internal medicine physician, as its medical reviewer. It states that its last medical-accuracy review occurred on October 13, 2025. That review date precedes the publication date.
The reviewer credit does not provide an independent specialist consensus or turn the article into a treatment guideline. The page also contains no direct quotation from the reviewer that supports attributing individual scientific conclusions to him.
This clinical explainer does not provide a basis for an immediate change in medical practice. Its most useful message is to keep symptoms, hormone measurements and supplement claims separate rather than treating one as proof of another.
For men with low energy or reduced libido, the practical next step is a discussion of possible causes with a qualified clinician. Testostra’s overview of placing symptoms alongside hormone measurements offers further educational context for that conversation.
Ubie advises discussing supplement use with a healthcare professional. Information relevant to that discussion includes:
These details support a clinical review of the concern without assuming either benefit or harm in advance. They also keep the focus on the person’s actual symptoms rather than on reproducing a percentage from an explainer.
The bottom line is restrained: tongkat ali remains a subject of research rather than a predictable answer to low energy or libido. This publication supports informed questions about the evidence and safety. It does not establish a new treatment standard or a reason to change hormone treatment independently.
Assuming tongkat ali will resolve low energy can turn an unexplained symptom into a supplement decision. Testostra addresses uncertainty about symptom causes through readable testosterone education, helping men place supplement claims in context rather than mistake a reported hormone change for an explanation of how they feel.
Testostra follows testosterone research, clinical guidance and emerging evidence without turning general information into personal treatment advice.
Send us a question, research idea or topic suggestion. Reader questions help shape future Testostra content.
Contact Testostra